சுஷில் சூரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from சுஷில் சூரி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In சுஷில் சூரி Today - Breaking & Trending Today
Morepen Laboratories Ltd posts consolidated PAT of Rs. 30.47 crore in Q1FY22 equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Morepen clocks 57 pc growth in Q1 PAT at Rs 30 crore russiaherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from russiaherald.com Daily Mail and Mail on Sunday newspapers.
India's Morepen Labs starts production of Russia's Sputnik V prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
Morepen Labs starts production of Russia's Sputnik V Covid-19 vaccine business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
New Delhi: Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288), a leading manufacturer of high-quality APIs, Home Diagnostics, Formulations and OTC products, yesterday approved incoming investment of Rs. 433 crore in the Extra-Ordinary General Meeting (EGM) of the company. The members approved the issue and allotment of 58.50 million equity shares for cash to Corinth Investment Holdings AG, Switzerland (www.corinthinvest.com) at Rs.41.60 per share aggregating to Rs. 243.36 crores.
Shareholders also approved 50 million fully convertible warrants to a promoter group company Liquid Holdings Private Limited at Rs.38 per warrant/share aggregating up to Rs. 190 crores for cash to be converted into equity within 18 months, within the limits prescribed in SEBI (SAST) Regulations for acquisition of share/ voting rights in a financial year. The issue price of aforesaid securities is derived as per pricing formula prescribed by SEBI in SEBI (ICDR) Regulations. ....